This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
TORONTO , July 19, 2021 /CNW/ – Halo Collective Inc. (“Halo” or the “Company”) (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN), a vertically integrated cannabis company, announced today that it has entered into a brand licensing arrangement (the “Licensing Agreement”) with Brezwald Corp. Related Links.
The authorization procedure for the extraction of active ingredients and the production of cannabis extracts was published by the Ministry of Health after an explicit request from the M5S. The Ministry of Health, at our request, has made public the authorization procedure for the manufacture of cannabis extracts on its portal .
regulators are planning a public hearing to collect more information on CBD in cosmetics, foods and other products as the cannabis compound spreads in popularity. People have been drawn to the extract because of its supposed calming effects. The FDA has approved a pharmaceutical version of CBD to treat rare seizure disorders.
Dr. Rungpetch Sakulbumrungsilp Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University. Dr. Rungpetch Sakulbumrungsilp, Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University, unlike the present in which many facets and aspects of cannabis are being studied in addition to the work of Chula C.A.N.S.,
We are one of the first to successfully complete a commercial shipment of Colombian-manufactured high-CBD pharmaceutical product to Germany available for patients in pharmacies under prescription. In addition, this reflects our increasing know-how to comply with complex and sophisticated regulatory and quality frameworks.
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.
Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. 30 May 2019.
Flora will now have the ability to quickly and efficiently reference and manage information at its cultivation and extraction facility, collect and analyze data, derive insights to find cost efficiencies, and ensure accuracy. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. About Applied DNA Sciences Inc.
Flora’s cultivation and extraction division, Cosechemos, completed construction of a 10,500 ft 2 state-of-the-art post-harvest and extraction facility with annual capacity of 15,000 L of distillate. At this time, the team is continuing commercial CBD extraction.
The statement confirms that the farm bill did not legalize products made with CBD extracted from hemp. The Minnesota Board of Pharmacy also goes on to state that the FDA doesn’t allow cannabinoid extracts the right to be sold under the category of dietary supplements.
2021 /CNW/ – Halo Collective Inc. (“Halo”) (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN), a vertically integrated multinational cannabis company, today announced that its board of directors has unanimously approved the reorganization (the “International Reorganization”) of its non-U.S. About Halo Collective Inc.
NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,
Join Us in Advancing Cannabis Science to Elevate the Industry , by Pelin Thorogood, Co-founder and Executive Chair of Radicle Science, and Nicole Brown, Chief Innovation Officer of Open Book Extracts. About Open Book Extracts. About Radicle Science. To learn more, please visit www.radiclescience.com and follow their LinkedIn page.
CSE: MXT) (OTCQB: MXTTF) is known for its award-winning extraction equipment, but recently, the company refocused its efforts on its proprietary health-related databases, machine learning analysis, and plans to engage in B2B licensing and mHealth. Medxtractor Corp. Mental health disorders are notoriously difficult to diagnose and treat.
To prepare for your appointment you will want to collect your medical records about the condition you wish to treat with medical cannabis. These oils are extracted by the licensed Pharmaceutical Processors that have been selected to grow, process, and dispense medical cannabis in Virginia.
The term does not include industrial hemp, as defined in state law, that is grown, dealt, or processed in compliance with state or federal law, unless it has been acquired and formulated with cannabis plant extract by a pharmaceutical processor. Next Steps for Employers.
(NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has received the Good Agricultural and Collection Practices (“GACP”) certification by the Control Union Medical Cannabis Standard (“CUMCS”). Cosechemos Operational Update.
It’s used by Federal statistical agencies for the collection and analysis of statistical data related to our economy. Now, the cannabis industry is relatively new, and no doubt federal statistical agencies are still figuring out how to collect data on the federally illegal, but state legal, cannabis industry.
21, 2019 (GLOBE NEWSWIRE) — Clever Leaves , a leading vertically-integrated licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, has received a pre-license letter from INFARMED I.P., million square feet of greenhouses under Good Agricultural and Collection Practices (GACP) in Colombia.
Her previous use of pharmaceutical medications provided only minor relief that came with a slew of side-effects. Look for CBD collected via CO2 extraction so you can be certain there are no traces of harmful herbicides or other chemicals present. They are guaranteed non-GMO and gluten-free. Have you tried CBD Oil for sleep?
Psilobrain is committed to our Drug Development Program, with 3 provisional patents and numerous preclinical studies in various stages of research and data collection. and is an active contributor in the pharmaceutical, nutraceutical and psychedelic wellness industries. VANCOUVER, BC , Nov. About HAVN Life Sciences Inc.
. (“Charlotte’s Web” or the “Company”), the world’s most trusted hemp extract and market leader in hemp-derived cannabidiol (“CBD”) wellness products , is pleased to announce that David Panter has joined the Company as Chief Operating Officer, effective March 30, 2020.
Pure Hemp Collective, Inc. In July of 2018, United Cannabis Corporation (“UCANN”) filed an infringement action against Pure Hemp Collective (“Pure Hemp”) in the United States District Court District of Colorado. Patent 1 , which claims various liquid formulations of enriched extracts of plant cannabinoids.
Construction of New Melbourne-area Extraction Facility on Schedule. TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its subsidiary MediPharm Labs Australia Pty. (TSX:
But as the pharmaceutical use is becoming more and more popular internationally, the province is also keen on developing the pharmaceutical sector. The government is also seeking cooperation partners on CBD extraction in Europe and North America by offering them an excellent infrastructure and investment subsidies.
. (“PharmaCielo” or the “Company”) (TSXV: PCLO ) (OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., and Canada. ” About PharmaCielo. Forward-Looking Statements.
In fact, the cannabis-related patent landscape has become increasingly crowded over the past five years with companies staking their early claims to growing methods, delivery methods, supply chain management, extraction techniques, vaporizers, medical treatments, pharmaceutical compositions, and more.
Products will be distributed through Valens’ Australian Distribution Partner, Cannvalate PTY Ltd (“Cannvalate”), and will be the largest quantity of products provided to Cannvalate for distribution to date (collectively, the “ Transaction “).
In addition to generating revenue from its education services, PURA expects to monetize its efforts by building a co-op of hemp growers and processors and selling the co-op’s collective products and services under the Farmersville Hemp brand name. OTC Pink: PAOG) in the development of CBD extractpharmaceuticals and nutraceuticals.
after alleging the pot producer failed to pay for millions of dollars’ worth of cannabis oil over a supply deal signed last year, the marijuana extraction company said in a court filing. As a global leader, MediPharm Labs has completed commercial exports to Australia and is nearing commercialization of its Australian extraction facility.
Since our founding, Folium has always employed a Chief Science Officer, and collectively our quality assurance department has over 75 years of experience in food and pharmaceuticals,” said Kashif Shan, Chief Executive Officer, and Co-Founder. CBD Isolate is an isolated, refined, and concentrated product.
This week, Ikänik announced its Latin American subsidiary, Pideka, received good agricultural and collection practice from the Colombian government for its Casa Flores cannabis camp. The new certification gives Pideka the ability to export pharmaceutical cannabis products, such as seeds and biomass, to European markets from Casa Flores.
TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce its participation at the BMO & TMX Hemp & Medical Cannabis Conference in London, UK on October 16, 2019.
Pet Releaf has created human grade products with proven positive results for animals through using the entire hemp plant, extracting the oil using a supercritical CO2 method, and making products using all-natural and organic ingredients. What was most upsetting was that there were no alternatives to the pharmaceuticals the vets were offering.
Moreover much of the research done has focused on synthetic pharmaceutical grade cannabinoids developed by pharmaceutical companies. Comparatively there has not been as much controlled clinical research on herbal cannabis or cannabis extracts. Studies with greater sample sizes and better data collection are sorely needed.
The extraction/distillation structure includes a uniquely-designed, highly-automated, computer-monitored mobile extraction unit designed by Canada-based extractX Inc. incorporating the most modern extraction and distillation equipment and processes.
Flora is building a connected, design-led collective, of plant-based wellness and lifestyle brands, that delivers the most compelling customer experiences in the world, one community at a time. About Flora Growth Corp.
The establishment of the genetics and cultivation advisor role comes as Flora ramps up cannabis production, including its recently completed EU-GMP compliant extraction lab. The appointment of Mr. Pedro supports Flora’s continued adaptation of proven genetics to the unique Colombian climate, at one of the lowest cost bases in the world.
On the topic of sustainability, Florida also currently lacks a dedicated patient or clinic “cannabis collection” station for used cannabis products; an integrated program for safe disposal here in Florida must be addressed, by the Medical Marijuana Advisory Committee or other dedicated state body. .
AJEM’s mission is to create, collect, and disseminate credible cannabis research data. 10 It informs the definition of hemp in the Agricultural Improvement Act of 2018, which holds that hemp-derived cannabinoids (and other extracts and compounds) are not controlled substances. Federal Register. 2019;84(168):45501-45502.
Kief and Hashish: this is the collected resin of mature and ripe cannabis flower buds. separating and collecting the resin can be accomplished by using a sieve or ice water. tinctures extracted using alcohol, glycerin, or oil form the basis of various medicinal creams, balms, and lotions. Pharmaceuticals include: .
Measure 1, Background of principals, board members, and owners: Applicants shall provide an overview of experience of principals, officers, and owners, in operating a regulated cannabis business, or operating a business in another highly regulated industry, such as healthcare, insurance, financial services, pharmaceuticals, or energy.
Acquisition of solventless cannabis extraction and enhanced delivery technology bolsters the company’s beverage portfolio with valuable IP, adding four innovative brands in the adult-use cannabis market and $17M in assets to the balance sheet. – Topicals infused with proprietary pharmaceutical delivery technology. Meridian Co.
Beyond the attractive collection of strategic assets and intellectual property that Dr. Kingsley has assembled, I have taken this role because I share the Company’s ambitious vision for the future of cannabis. Vireo’s physician-led team of more than 400 employees provides best-in-class cannabis products and customer experience.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content